Pharmather Holdings Stock Total Debt
PHRRF Stock | USD 0.15 0.01 7.14% |
Pharmather Holdings fundamentals help investors to digest information that contributes to Pharmather Holdings' financial success or failures. It also enables traders to predict the movement of Pharmather OTC Stock. The fundamental analysis module provides a way to measure Pharmather Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pharmather Holdings otc stock.
Pharmather |
Pharmather Holdings OTC Stock Total Debt Analysis
Pharmather Holdings' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition |
Based on the latest financial disclosure, Pharmather Holdings has a Total Debt of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The total debt for all United States stocks is 100.0% higher than that of the company.
Pharmather Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pharmather Holdings' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Pharmather Holdings could also be used in its relative valuation, which is a method of valuing Pharmather Holdings by comparing valuation metrics of similar companies.Pharmather Holdings is currently under evaluation in total debt category among its peers.
Pharmather Fundamentals
Return On Equity | -0.63 | |||
Return On Asset | -0.25 | |||
Current Valuation | (3.24 M) | |||
Shares Outstanding | 88.17 M | |||
Shares Owned By Insiders | 18.67 % | |||
Shares Owned By Institutions | 0.06 % | |||
Price To Earning | 2.26 X | |||
Price To Book | 0.57 X | |||
EBITDA | (4.1 M) | |||
Net Income | (4.01 M) | |||
Cash And Equivalents | 10.15 M | |||
Cash Per Share | 0.12 X | |||
Current Ratio | 70.26 X | |||
Book Value Per Share | 0.09 X | |||
Cash Flow From Operations | (3.51 M) | |||
Earnings Per Share | (0.04) X | |||
Beta | 2.98 | |||
Market Capitalization | 13.44 M | |||
Total Asset | 12.16 M | |||
Net Asset | 12.16 M |
About Pharmather Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharmather Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmather Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmather Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Pharmather OTC Stock
Pharmather Holdings financial ratios help investors to determine whether Pharmather OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmather with respect to the benefits of owning Pharmather Holdings security.